| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 7.231 | 8.319 | 288.189 | 423.954 |
| Total Income - EUR | - | - | - | - | - | - | 7.231 | 8.319 | 288.977 | 428.366 |
| Total Expenses - EUR | - | - | - | - | - | - | 5.200 | 8.049 | 29.241 | 50.592 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 2.030 | 270 | 259.736 | 377.775 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 1.813 | 20 | 256.846 | 365.181 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Diabcaresm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 740 | 371 | 4.002 | 12.866 |
| Current Assets | - | - | - | - | - | - | 2.432 | 3.296 | 265.225 | 673.901 |
| Inventories | - | - | - | - | - | - | 0 | 907 | 418 | 2.306 |
| Receivables | - | - | - | - | - | - | 940 | 487 | 21.672 | 334.279 |
| Cash | - | - | - | - | - | - | 1.492 | 1.902 | 243.135 | 96.075 |
| Shareholders Funds | - | - | - | - | - | - | 1.853 | 1.879 | 258.719 | 365.263 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.318 | 1.787 | 10.507 | 321.504 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diabcaresm S.r.l.